Title | Progress in Tumor Research |
Abbreviation | Prog. Tumor Res. |
Publication Type | Book series |
Subject Area, Categories, Scope | Cancer Research (Q4); Oncology (Q4) |
h-index | 12 |
Overall Rank/Ranking | 20701 |
SCImago Journal Rank (SJR) | 0.158 |
Impact Score | 0.00 |
Publisher | S. Karger AG |
Country | Switzerland |
ISSN | 22961887 |
Best Quartile | Q4 |
Coverage History | 2014-2016, 2018 |
Progress in Tumor Research is a book series covering the technologies/fields/categories related to Cancer Research (Q4); Oncology (Q4). It is published by S. Karger AG. The overall rank of Progress in Tumor Research is 20701. According to SCImago Journal Rank (SJR), this book series is ranked 0.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 12. The best quartile for this book series is Q4.
The ISSN of Progress in Tumor Research book series is 22961887. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Progress in Tumor Research is cited by a total of 3 articles during the last 3 years (Preceding 2021).
The Impact IF 2021 of Progress in Tumor Research is 0.00, which is computed in 2022 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2021 | 0.00 |
2020 | 0.10 |
2019 | 0.10 |
2018 | 2.08 |
2017 | 1.52 |
2016 | 1.26 |
2015 | 2.00 |
2014 | 0.00 |
Progress in Tumor Research has an h-index of 12. It means 12 articles of this book series have more than 12 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Progress in Tumor Research is 22961887. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Progress in Tumor Research is 20701. According to SCImago Journal Rank (SJR), this book series is ranked 0.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2021 | 0.158 |
2020 | 0.106 |
2019 | 0.254 |
2018 | 0.858 |
2017 | 0.682 |
2016 | 0.398 |
2015 | 0.533 |
2014 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2021 | 20701 |
2020 | 29484 |
2019 | 16025 |
2018 | 5379 |
2017 | 6958 |
2016 | 11073 |
2015 | 8728 |
2014 | 32694 |
Progress in Tumor Research is published by S. Karger AG. It's publishing house is located in Switzerland. Coverage history of this book series is as following: 2014-2016, 2018. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Progress in Tumor Research is Prog. Tumor Res.. This abbreviation ('Prog. Tumor Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q4); Oncology (Q4), then please visit the official website of this book series.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Progress in Tumor Research latest impact IF is 0.00. It's evaluated in the year 2021. The highest and the lowest impact IF or impact score of this book series are 2.08 (2018) and 0.00 (2021), respectively, in the last 8 years. Moreover, its average IS is 0.88 in the previous 8 years.
The Progress in Tumor Research has an SJR (SCImago Journal Rank) of 0.158, according to the latest data. It is computed in the year 2022. In the past 8 years, this book series has recorded a range of SJR, with the highest being 0.858 in 2018 and the lowest being in 2014. Furthermore, the average SJR of the Progress in Tumor Research over the previous 8-year period stands at 0.88.
The latest h-index of the Progress in Tumor Research is 12.
The Progress in Tumor Research is published by the S. Karger AG, with its country of publication being the Switzerland.
The Progress in Tumor Research is currently ranked 20701 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this book series has experienced varying rankings, reaching its highest position of 5379 in 2018 and its lowest position of 32694 in 2014.
The standard ISO4 abbreviation for the Progress in Tumor Research is Prog. Tumor Res..
Progress in Tumor Research is classified as a book series that the S. Karger AG publishes.
The Progress in Tumor Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this book series.
The Progress in Tumor Research is assigned the following International Standard Serial Numbers (ISSN): 22961887.
The best quartile for the Progress in Tumor Research is Q4 (2021).
The Progress in Tumor Research coverage history can be summarized as follows: 2014-2016, 2018.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
Applied Ecology and Environmental Research | journal | 17545 | Corvinus University of Budapest | 38 | 0.74 |
Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
Materials Research | journal | 14791 | Universidade Federal de Sao Carlos | 65 | 1.62 |
Canadian Journal of Education | journal | 17961 | Canadian Society for the Study of Education (CSSE) | 41 | 0.39 |
Libyan Studies | journal | 16122 | Cambridge University Press | 8 | 0.45 |
Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
Journal of Immigrant and Refugee Studies | journal | 9246 | Routledge | 32 | 1.46 |
Year | Impact Score (IS) |
---|---|
2022/2023 | Coming Soon |
2021 | 0.00 |
2020 | 0.10 |
2019 | 0.10 |
2018 | 2.08 |
2017 | 1.52 |
2016 | 1.26 |
2015 | 2.00 |
2014 | 0.00 |